Soria, J-C.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Genomic profile in pulmonary neuroendocrine tumors (puNETs): the whole-exome sequencing (WES) as a strategic tool

Sullivan, I.G., Deloger, M., Lacroix, L., Job, B., Dorvault, N., Adam, J., Honore, A., Gianoncelli, L., Le Teuff, G., de Montpreville, V., Besse, B., Soria, J-C., Scoazec, J-Y., Baudin, E., Planchard,

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 67 KB

english, 2016

2

A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer

Postel-Vinay, S, Bajrami, I, Friboulet, L, Elliott, R, Fontebasso, Y, Dorvault, N, Olaussen, K A, André, F, Soria, J-C, Lord, C J, Ashworth, A

Journal:

Year:

2013

Language:

english

File:

PDF, 3.19 MB

english, 2013

3

Immune checkpoint inhibitors (IC) induce paradoxical progression in a subset of non-small cell lung cancer (NSCLC)

Lahmar, J., Mezquita, L., Koscielny, S., Facchinetti, F., Bluthgen, M.V., Adam, J., Gazzah, A., Remon, J., Planchard, D., Soria, J-C., Caramella, C., Besse, B.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 36 KB

english, 2016

4

1482PDNotch pathway inhibition with LY3039478 in soft tissue sarcoma (STS) and gastrointestinal stromal tumours (GIST)

Mir, O., Azaro, A., Merchan, J.R., Chugh, R., Trent, J.C., Rodon, J., Ohnmacht, U., Smith, C., Oakley III, G.J., Le Cesne, A., Soria, J-C., Benhadji, K., Massard, C.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 79 KB

english, 2017

5

446PD Second-line afatinib vs erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumor and serum biomarkers

Lee, K.H., Soria, J-C., Felip, E., Cobo, M., Lu, S., Syrigos, K., Goker, E., Georgoulias, V., Li, W., Guclu, S., Isla, D., Ardizzoni, A., Gadgeel, S.M., Dupuis, N., Gibson, N.J., Krämer, N., Bühnemann

Journal:

Annals of Oncology

Year:

2016

File:

PDF, 87 KB

2016

6

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients

Ady, N, Morat, L, Fizazi, K, Soria, J-C, Mathieu, M-C, Prapotnich, D, Sabatier, L, Chauveinc, L

Journal:

British Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 137 KB

english, 2004

7

ANSELMA: ANtiangiogneic SEcond line Lung cancer Meta-Analysis in non-small cell lung cancer (NSCLC)

Masip, J. Remon, Thuong, C-T., Pignon, J-P., Lacas, B., Soria, J-C., Besse, B.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 35 KB

english, 2016

8

1300PBUPARLISIB (BKM120) IN PATIENTS WITH PI3K PATHWAY-ACTIVATED, METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM THE BASALT-1 STUDY

Soria, J-C., Vansteenkiste, J.F., Canon, J., Reck, M., Gridelli, C., Grossi, F., De Pas, T., Gray, J., Felip, E., Su, W., Yoshioka, H., Dy, G.K., Thomas, M., De Greve, J., Roussou, P., Atalla-Vidam, G

Journal:

Annals of Oncology

Year:

2014

File:

PDF, 69 KB

2014

9

92PDetection of PIK3CA mutation by circulating DNA during chemotherapy: A tool to identify hard-to-treat metastatic breast cancers

Mosele, F, Lusque, A, Tran Dien, A, Droin, N, Le Tourneau, C, Sablin, M P, Lacroix, L, Miran, I, Jovelet, C, Bieche, I, Soria, J-C, Bertucci, F, Bonnefoi, H, Campone, M, Dalenc, F, Bachelot, T, Jacque

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 78 KB

2019

10

1703PDLandscape of DNA damage response (DDR) genes alterations in the prospective MOSCATO and MATCH R trials

El Dakdouki, Y., Verlingue, L., Massard, C., Bahleda, R., Hollebecque, A., Mahjoubi, L., Rouleau, E., Lacroix, L., Auger, N., Scoazec, J-Y., Solary, E., Marabelle, A., André, F., Soria, J-C., Postel-V

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 78 KB

english, 2017

11

296PApplicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs)

Vozy, A, Simonaggio, A, Auclin, E, Mezquita, L, Baldini, C, Martin-Romano, P, Pistilli, B, Gazzah, A, Bahleda, R, Ribrag, V, Postel-Vinay, S, Champiat, S, Soria, J-C, André, F, Massard, C, Besse, B, D

Journal:

Annals of Oncology

Year:

2018

File:

PDF, 79 KB

2018

12

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Krug, A K, Enderle, D, Karlovich, C, Priewasser, T, Bentink, S, Spiel, A, Brinkmann, K, Emenegger, J, Grimm, D G, Castellanos-Rizaldos, E, Goldman, J W, Sequist, L V, Soria, J-C, Camidge, D R, Gadgeel

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 654 KB

english, 2017

13

1332TiPTWO PHASE III STUDIES EVALUATING CERITINIB IN PATIENTS (PTS) WITH ANAPLASTIC LYMPHOMA KINASE (ALK)-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC): ASCEND-4 AND ASCEND-5

Shaw, A., Tan, D.S.W., Crinò, L., Felip, E., Mok, T.S.K., Nishio, M., Paz-Ares, L., Scagliotti, G., Spigel, D.R., Wolf, J., Wu, Y., Castro, G., Sen, P., Zheng, C., Joe, A., Soria, J-C

Journal:

Annals of Oncology

Year:

2014

File:

PDF, 68 KB

2014

14

124INPHASE I CANCER DRUG DEVELOPMENT IN EUROPE

Journal:

Annals of Oncology

Year:

2014

File:

PDF, 60 KB

2014

15

Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small cell lung cancer

Soria, J-C, Ho, S N, Varella-Garcia, M, Iafrate, A J, Solomon, B J, Shaw, A T, Blackhall, F, Mok, T S, Wu, Y-L, Pestova, K, Wilner, K D, Polli, A, Paolini, J, Lanzalone, S, Green, S, Camidge, D R

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 760 KB

english, 2018

16

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

Loriot, Y, Mordant, P, Dorvault, N, De la motte Rouge, T, Bourhis, J, Soria, J-C, Deutsch, E

Journal:

British Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 464 KB

english, 2010

17

Towards a comprehensive climate change agreement in Copenhagen

Russ, P, Ciscar, J-C, Saveyn, Bert, Soria, A, Szabo, L, Ierl, T Van, Klaassen, G, Virdis, R

Journal:

IOP Conference Series Earth and Environmental Science

Year:

2009

Language:

english

File:

PDF, 324 KB

english, 2009

18

Safety and activity of the pan–fibroblast growth factor receptor (FGFR) inhibitor erdafitinib in phase 1 study patients with advanced urothelial carcinoma

Soria, J-C., Italiano, A., Cervantes, A., Tabernero, J., Infante, J., Lara, P.N., Spira, A., Calvo, E., Moreno, V., Blay, J-Y., Lauer, R., Chan, N., Zhong, B., Santiago-Walker, A. Ademi, Bussolari, J.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 43 KB

english, 2016

19

1163PImmunotherapy phase I trials in patients over 70 years with advanced solid tumours: The Gustave Roussy experience

Herin, H., Castanon, E., Dyevre, V., Aspeslagh, S., Marabelle, A., Postel-Vinay, S., Varga, A., Gazzah, A., Ribrag, V., Bahleda, R., Michot, J-M., Mir, O., Massard, C., Hollebecque, A., Soria, J-C., B

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 45 KB

english, 2017

20

439PProspective validation of prognostic scores to improve patient selection for immuno-oncology trials

Massard, C, Segal, N H, Cho, D C, Papadimitrakopoulou, V A, Rizvi, N A, Cho, B C, Yu, L, Yang, H, Hsieh, H-J, Zhang, J, Zhao, W, Gao, G, Guo, X, Abdullah, S, Englert, J, Soria, J-C, Dar, M, Roskos, L,

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 82 KB

english, 2018

21

1300PBUPARLISIB (BKM120) IN PATIENTS WITH PI3K PATHWAY-ACTIVATED, METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM THE BASALT-1 STUDY

Soria, J-C., Vansteenkiste, J.F., Canon, J., Reck, M., Gridelli, C., Grossi, F., De Pas, T., Gray, J., Felip, E., Su, W., Yoshioka, H., Dy, G.K., Thomas, M., De Greve, J., Roussou, P., Atalla-Vidam, G

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 69 KB

english, 2014

22

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C, Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A., Massard, Christophe

Journal:

Investigational New Drugs

Year:

2019

Language:

english

File:

PDF, 746 KB

english, 2019

23

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

Ploquin, A, Olmos, D, Lacombe, D, A'Hern, R, Duhamel, A, Twelves, C, Marsoni, S, Morales-Barrera, R, Soria, J-C, Verweij, J, Voest, E E, Schöffski, P, Schellens, J H, Kramar, A, Kristeleit, R S, Arken

Journal:

British Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 318 KB

english, 2012

24

1634PFGFR pathway genomic aberrations and response to FGFRs inhibitors

Faure, M., Hollebecque, A., Bahleda, R., Soria, J-C., Dyevre, V.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 51 KB

english, 2017

25

31PMATCH-R development of preclinical models from patient with acquired resistance to targeted therapy

Bigot, L, Deas, O, Lang, G, André, F, Caro, S, Friboulet, L, Loriot, Y, Judde, J-G, Besse, B, Soria, J-C

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 73 KB

english, 2018

26

1930O Genomic alterations in solid tumours according to ESMO scale for clinical actionability of molecular targets (ESCAT)

Martin Romano, P., Mezquita, L., Lacroix, L., Rouleau, E., Varga, A., Baldini, C., Postel-Vinay, S., Friboulet, L., Geraud, A., Aldea, M., Gazzah, A., Loriot, Y., Soria, J-C., AndrÃ©, F., Hollebecque,

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 181 KB

2020

27

Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism

Morel, D., Almouzni, G., Soria, J-C., Postel-Vinay, S.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 872 KB

english, 2016

28

Rociletinib-associated cataracts in EGFR-mutant NSCLC

Piotrowska, Z., Liu, E., Varga, A., Thakur, M., Narayanan, V., Liu, S.V., Neal, J., Spiegel, M., Solomon, B., Yu, H., Ou, S-H.I., Papadimitrakopoulou, V.A., Gadgeel, S., Camidge, D.R., Soria, J-C., Wa

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 41 KB

english, 2016

29

112PPathological evaluation of tumor infiltrating lymphocytes and the benefit of nivolumab in advanced non-small cell lung cancer (NSCLC)

Gataa, I., Mezquita, L., Auclin, E., Le Moulec, S., Alemany, P., Kossai, M., Massé, J., CARAMELLA, C., Remon Masip, J., Lahmar, J., Ferrara, R., Gazzah, A., Soria, J-C., Planchard, D., Besse, B., Adam

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 77 KB

2017

30

1171PCheckpoint inhibitors in MSI tumors: Lessons from a monocentric experience

El Dakdouki, Y., Verlingue, L., Massard, C., Leary, A., Lacroix, L., Rouleau, E., Scoazec, J-Y., Caron, O., Benusiglio, P., Kannouche, P., Hollebecque, A., Malka, D., Soria, J-C., Marabelle, A.

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 91 KB

2017

31

26PA combination of resistance mechanisms is frequent in non-small cell lung cancer (NSCLC) that progressed to EGFR tyrosine kinase inhibitors (TKIs)

Enrico, D H, Lacroix, L, Rouleau, E, Scoazec, J-Y, Loriot, Y, Tselikas, L, Jovelet, C, Planchard, D, Gazzah, A, Mezquita, L, Ngo, M, Michiels, S, Maillard, A, Massard, C, Facchinetti, F, Soria, J-C, A

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 89 KB

2019

32

Osimertinib in EGFR T790M positive advanced NSCLC (aNSCLC) – real–life data from the French temporary authorization for use (ATU) program

Planchard, D., Pérol, M., Quantin, X., Cortot, A., Cadranel, J., Schott, R., Dansin, E., Fraboulet, G., Moro-Sibilot, D., Soria, J-C., Mazieres, J., Moulec, S. Le, Coudurier, M., Pichon, E., Licour, M

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 49 KB

english, 2016

33

86OAfatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far

Smit, E., Soria, J-C., Janjigian, Y.Y., Groen, H.J.M., Pao, W., Calvo, E., Gazzah, A., Fan, J., Ould-Kaci, M., Horn, L.

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 89 KB

2017

34

hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway

Massard, C, Zermati, Y, Pauleau, A-L, Larochette, N, Métivier, D, Sabatier, L, Kroemer, G, Soria, J-C

Journal:

Year:

2006

Language:

english

File:

PDF, 278 KB

english, 2006

35

A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma

Boutros, C., Mateus, C., Routier, E., Chouaib, S., Libenciuc, C., Reigneau, M., Girault, I., Caramella, C., Hibat, S., Vagner, S., Tao, Y.G., Chaput, N., Adam, J., Soria, J-C., Eggermont, A., Deutsch,

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 38 KB

english, 2016

36

84PDRelationship of PD-L1 and a T-cell inflamed gene expression profile (GEP) to clinical response in a multicohort trial of solid tumors (KEYNOTE [KN]028)

Ott, P.A., Bang, Y-J., Razak, A.R.A., Bennouna, J., Soria, J-C., Rugo, H.S., Cohen, R.B., O'Neil, B.H., Mehnert, J.M., Lopez, J., Doi, T., van Brummelen, E., Levitan, D., Zhao, G., Emancipator, K., St

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 77 KB

english, 2017

37

1323PBaseline corticosteroids (CS) could be associated with absence of benefit to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients

Martínez Bernal, G., Mezquita, L., Auclin, E., Ferrara, R., Planchard, D., Remon Masip, J., Lahmar, J., Boucher, M-E., Caramella, C., Adam, J., Gazzah, A., Soria, J-C., Besse, B.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 49 KB

english, 2017

38

21OEPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

Lindsay, C R, Blackhall, F H, Carmel, A, Gazzaniga, P, Groen, H J M, Krebs, M G, Muinelo-Romay, L, Pantel, K, Rossi, E, Terstappen, L, Wikman, H, Soria, J-C, Farace, F F, Renehan, A, Dive, C, Besse, B

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 94 KB

2019

39

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells

Farace, F, Massard, C, Borghi, E, Bidart, J-M, Soria, J-C

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 177 KB

english, 2007

40

Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer

Taillade, L, Penault-Llorca, F, Boulet, T, Fouret, P, Michiels, S, Taranchon, E, Mountzios, G, Validire, P, Domont, J, Girard, P, Grunenwald, D, Le Chevalier, T, Soria, J-C

Journal:

Annals of Oncology

Year:

2007

Language:

english

File:

PDF, 421 KB

english, 2007

41

Is anti-PD-1/PD-L1 immunotherapy sensitizing for conventional cancer therapies?

Matias, M., Aspeslagh, S., Palomar, V., Lanoy, E., Dercle, L., Even, C., Ferte, C., Hollebecque, A., Marabelle, A., Massard, C., Soria, J-C., Postel-Vinay, S.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 40 KB

english, 2016

42

22INOVERVIEW OF TRIALS TESTING TUMOUR MOLECULAR PROFILING

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 33 KB

english, 2014

43

102PLUX-Lung 8 phase III trial: Analysis of long-term response to second-line afatinib in patients with advanced squamous cell carcinoma (SCC) of the lung

Yang, J.C-H., Goss, G., Felip, E., Lu, S., Ardizzoni, A., Gadgeel, S.M., Georgoulias, V., Dupuis, N., Ehrnrooth, E., Soria, J-C.

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 78 KB

2017

44

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

Vicent, S, López-Picazo, J M, Toledo, G, Lozano, M D, Torre, W, Garcia-Corchón, C, Quero, C, Soria, J-C, Martín-Algarra, S, Manzano, R G, Montuenga, L M

Journal:

British Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 165 KB

english, 2004

45

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

Tsao, M-S., Le Teuff, G., Shepherd, F.A., Landais, C., Hainaut, P., Filipits, M., Pirker, R., Le Chevalier, T., Graziano, S., Kratze, R., Soria, J-C., Pignon, J-P., Seymour, L., Brambilla, E.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 284 KB

english, 2017

46

Epigenetic modifiers as new immunomodulatory therapies in solid tumours

Aspeslagh, S, Morel, D, Soria, J-C, Postel-Vinay, S

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 897 KB

english, 2018

47

1164PPatterns of progression under antiPD1/PDL1 in advanced NSCLC patients allow discriminating pseudo-progression from real progression

Caramella, C., Tazdait, M., Mezquita, L., Lahmar, J., Ferrara, R., Marabelle, A., Balleyguier, C., Planchard, D., Gazzah, A., Soria, J-C., Besse, B.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 45 KB

english, 2017

48

Detection of circulating carcinoma cells by telomerase activity

Gauthier, L R, Granotier, C, Soria, J-C, Faivre, S, Boige, V, Raymond, E, Boussin, F D

Journal:

British Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 72 KB

english, 2001

49

Phase I, safety, tolerability and preliminary efficacy study of tremelimumab (Trem) in combination with gefitinib (Gef) in EGFR-mutant (EGFR-mut) NSCLC (GEFTREM)

Planchard, D., Barlesi, F., Gomez-Roca, C., Mazieres, J., Varga, A., Greillier, L., Chaput, N., Parlavecchio, C., Malekzadeh, K., Ngocamus, M., Zahi, S., Besse, B., Lanoy, E., Soria, J-C.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 40 KB

english, 2016

50

Biomarkers in cancer immunotherapy: analysis of clinical, histological and immunohistochemical factors associated with PD-L1 status

Bellesoeur, A., Massard, C., Soria, J-C.

Journal:

Annals of Oncology

Year:

2016

File:

PDF, 61 KB

2016

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски